Hexarelin Pre-Research Checklist: What to Verify Before You Order

A hexarelin pre-research checklist comes down to four verifications a business buyer can finish before the purchase order goes out: confirmed compound identity and purity backed by a batch-specific certificate of analysis, a supplier whose testing you can inspect yourself rather than take on trust, pricing and minimum-order terms transparent enough to model against your own catalog, and a documented receiving, storage and inventory plan for the material once it lands. Hexarelin is a research-use-only compound. Nothing below describes human use, dosing or administration, and nothing here is legal advice for your business.

Most wholesale buyers work the list in the wrong order. They start with unit price, negotiate volume, and only ask about documentation once a shipment is already inbound. Reversing that sequence costs nothing and removes most of the ways a research-compound line item goes wrong.

Start with compound identity, not the quote

Hexarelin is a synthetic peptide in the growth hormone secretagogue family — the same broad research category that includes compounds like Ipamorelin and CJC-1295 No DAC. Published research on this class has focused largely on receptor signaling and growth hormone release in laboratory models, and studies indicate the mechanisms differ meaningfully between compounds that look superficially similar on a catalog page. That matters for sourcing: two suppliers can list the same name and ship materials that are not equivalent in any analytically meaningful sense.

So your first question is narrow. What exactly is being quoted? Confirm the compound name as it appears on the label, the salt form, and — the detail most buyers skip — whether the stated milligram figure refers to gross vial weight or net peptide content. Synthetic peptides are typically supplied as salts and carry residual water and counter-ion mass, so gross weight and peptide content are not the same number. A supplier that cannot tell you which one the label refers to is telling you something about how closely they read their own documentation.

Ask, too, whether the material is supplied lyophilized and what the labeled appearance should be on arrival. You want a written expectation before the box opens, so that a receiving discrepancy is an objective finding rather than an argument.

What a batch certificate of analysis actually proves

A certificate of analysis is only useful if it is tied to the specific lot in your hands. A generic COA — one representative document covering a product line rather than a production batch — proves that a supplier once tested something. It says nothing about the vial on your shelf. Before you order, establish three things: that COAs are lot-specific, that the lot number on the certificate will match the lot number printed on the label, and that you can see the document before you commit rather than after.

The second question is what the certificate contains. A purity percentage with no supporting data behind it is a claim, not evidence. High-performance liquid chromatography is the standard analytical method for peptide purity, and a meaningful COA shows the chromatogram, not just the resulting number. Mass spectrometry supports identity by confirming the molecular mass matches the expected structure. Beyond identity and purity, batch panels commonly extend to checks such as water content, residual solvents, heavy metals, endotoxin and microbial burden — the categories vary by supplier and by intended research application, which is exactly why the panel composition should be on the document rather than described verbally.

The third question is accessibility, and it separates serious suppliers from the rest of the market quickly. Some sellers email a COA only after purchase. Some charge for it. Some supply a PDF with the lab name, dates and chromatogram stripped out. Any of those practices should move a supplier down your list, because each one removes your ability to verify independently. Publicly posted, lot-matched results that a buyer can pull up without asking permission are the practical benchmark.

Receiving, storage and inventory before the shipment lands

The checklist does not end at purchase. Lyophilized research peptides are sensitive materials, and the conditions they sit in after delivery determine whether the COA you verified still describes what is on your shelf six months later. Decide in advance where material will be stored, who has access, what temperature range you are committing to, and how you will handle a shipment that arrives outside it.

Build a receiving step that someone actually performs rather than assumes. At minimum: confirm the lot number on each vial against the packing documentation, confirm it against the certificate you verified before ordering, record the receipt date, and photograph anything that looks inconsistent with the labeled description before it goes into storage. A quarantine shelf for discrepancies is a small operational habit that saves a disputed credit later.

Then keep the paperwork. Lot numbers, COAs, receiving records and storage logs should be retained in a form you can retrieve by lot, not buried in an inbox. If a question is ever raised about a specific batch, the ability to reconstruct where it came from, when it arrived and how it was held is the entire value of the record. Handling parameters, reconstitution planning and protocol design belong to your research director and your own written procedures — a supplier's role is to tell you what the material is and what testing supports that, not to design your protocol.

Supplier terms that decide whether the line item is worth stocking

Once documentation checks out, the commercial questions matter. Margins and order economics vary widely with volume, category and how a business positions its catalog, so treat any supplier who quotes you a profitability figure with suspicion — they cannot know your cost structure. What you can evaluate is the structure of the terms themselves.

Ask how pricing tiers are determined and whether the thresholds are published. Hidden pricing is common in this market and it has a predictable consequence: you cannot forecast, and you cannot tell whether a quoted price reflects your volume or the salesperson's mood that week. Ask how minimum order quantities work per compound and whether a mixed order counts toward a tier. Ask what happens to pricing when you reorder — specifically, whether the price you were quoted holds and how changes are communicated.

Then ask the operational questions. Where does fulfillment originate, and what is the realistic path from order to delivery? Domestic fulfillment materially shortens that path and removes an entire class of customs and transit variables. What is the process when a shipment is short, damaged or mismatched to the packing slip — who documents it, and on what timeline? How consistent is the catalog, and will a compound you build a listing around still be available next quarter? Lot-to-lot consistency deserves its own question: a supplier who tests every batch and posts those results publicly is giving you a way to check consistency yourself across reorders instead of taking a reassurance.

Compliance questions that belong with your own counsel

This section describes questions to raise, not answers to rely on. The regulatory treatment of research-use-only compounds, who may purchase them, how they may be labeled and what a business may or may not do with them downstream is not something an article can settle for you — it depends on your business model, your professional licensure and the jurisdictions you operate in. Generally speaking, research-use-only materials are not approved drugs and are not supplied for human consumption, and that framing should be reflected consistently in how your business describes anything it stocks.

The practical move is to bring your attorney a specific list rather than a general worry. Reasonable items: how research-use-only materials should be labeled and described in your own catalog and marketing; what your state board, if you hold a professional license, expects regarding materials held on your premises; what record-keeping obligations attach to purchase and resale in your situation; and what claims your marketing team may not make. Check with your state board and your attorney before you build a process around an assumption. If your protocol involves animal models, the attending veterinarian and the review committee overseeing that work — not your supplier — are the parties to talk to before any material is used, and they should tell you what source documentation they expect to see.

None of this is legal advice, and no supplier, including Real Peptides, can give you a compliance conclusion for your business.

What Real Peptides does differently

Real Peptides supplies research compounds to businesses through its Wholesale Partner Program, and the model is built around the verifications above rather than around a sales conversation. Every compound is produced to 99%+ HPLC purity. Every batch goes through 7-panel testing, and the certificates of analysis are publicly verifiable — a prospective buyer can read the lab results for a batch before spending anything, rather than requesting documents after payment or paying for them separately. That is the point of posting them: verification should not depend on a supplier's willingness to send a file.

Fulfillment is US-based, with orders shipping in 5–7 days, which keeps reorder planning on a predictable footing instead of an international transit estimate. Pricing tiers and program terms are presented to applicants directly rather than negotiated in the dark. Becoming a partner is a 3-step wholesale application — apply, get reviewed and approved, then order at partner pricing.

Turning the checklist into a purchase order

If you have worked through identity, documentation, handling and terms and you are evaluating suppliers for a research-compound catalog, the Wholesale Partner Program application at realpeptides.co is the next step — review the posted COAs first, then apply, so the documentation is verified before the commercial conversation starts.

Buyers building out a research catalog can review the popular peptides collection and the more specialized growth factor and tissue signaling research and performance and recovery research categories, where individual listings such as Tesamorelin 10mg and BPC-157 10mg carry the same batch documentation standard described above.

Research Use and Legal Notice

All compounds discussed on this page are sold for research use only and are not for human consumption.

This page is general information and is not legal advice. Consult your attorney about the rules that apply to your business.